Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Burkhoff

Showing results (181-190 of 484) with videos related to

Pageof 49
Sort By:
JACC. Heart Failure|April 2, 2021
Reply: Pulmonary Artery Catheter in Cardiogenic Shock: Will the Benefits Finally Outweigh the Costs and Complications?A Reshad Garan, Manreet Kanwar, Jaime Hernandez-Montfort, et al.
The American Journal of Cardiology|March 10, 2009
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%Kun-Lun He, Daniel Burkhoff, Wen-Xiu Leng, et al.
Circulation. Heart Failure|July 9, 2024
Pulmonary Artery Pressures and Mortality During Venoarterial ECMO: An ELSO Registry AnalysisClark G Owyang, Brady Rippon, Felipe Teran, et al.
Journal of Cardiac Failure|November 13, 2025
First In-human study of a Novel Left Atrial Pressure Sensor: the Microtech LVAD StudyBinyamin Ben-Avraham, Ehud Jacobson, Yoram Richter, et al.
Frontiers in Cardiovascular Medicine|October 2, 2020
Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic ShockEvan H Whitehead, Katherine L Thayer, Daniel Burkhoff, et al.
ESC Heart Failure|August 14, 2021
Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trialWilliam T Abraham, Daniel Bensimhon, Sean P Pinney, et al.
Journal of Cardiac Failure|June 18, 2021
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP TrialMichael I Brener, Nadira B Hamid, Kenji Sunagawa, et al.
American Heart Journal|October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristicsWilliam T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Journal of Cardiac Failure|August 25, 2024
Racial Differences of Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionHidemi Sorimachi, Masaru Obokata, Kazunori Omote, et al.
JACC. Heart Failure|January 8, 2016
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?Daniel Burkhoff, Mathew S Maurer, Susan Joseph, et al.
Pageof 49

Showing results (181-190 of 484) with videos related to

Sort By:
Pageof 49
JACC. Heart Failure|April 2, 2021
Reply: Pulmonary Artery Catheter in Cardiogenic Shock: Will the Benefits Finally Outweigh the Costs and Complications?A Reshad Garan, Manreet Kanwar, Jaime Hernandez-Montfort, et al.
The American Journal of Cardiology|March 10, 2009
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%Kun-Lun He, Daniel Burkhoff, Wen-Xiu Leng, et al.
Circulation. Heart Failure|July 9, 2024
Pulmonary Artery Pressures and Mortality During Venoarterial ECMO: An ELSO Registry AnalysisClark G Owyang, Brady Rippon, Felipe Teran, et al.
Journal of Cardiac Failure|November 13, 2025
First In-human study of a Novel Left Atrial Pressure Sensor: the Microtech LVAD StudyBinyamin Ben-Avraham, Ehud Jacobson, Yoram Richter, et al.
Frontiers in Cardiovascular Medicine|October 2, 2020
Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic ShockEvan H Whitehead, Katherine L Thayer, Daniel Burkhoff, et al.
ESC Heart Failure|August 14, 2021
Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trialWilliam T Abraham, Daniel Bensimhon, Sean P Pinney, et al.
Journal of Cardiac Failure|June 18, 2021
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP TrialMichael I Brener, Nadira B Hamid, Kenji Sunagawa, et al.
American Heart Journal|October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristicsWilliam T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Journal of Cardiac Failure|August 25, 2024
Racial Differences of Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionHidemi Sorimachi, Masaru Obokata, Kazunori Omote, et al.
JACC. Heart Failure|January 8, 2016
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?Daniel Burkhoff, Mathew S Maurer, Susan Joseph, et al.
Pageof 49